These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 20180642)

  • 1. Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs.
    White NM; Bui A; Mejia-Guerrero S; Chao J; Soosaipillai A; Youssef Y; Mankaruos M; Honey RJ; Stewart R; Pace KT; Sugar L; Diamandis EP; Doré J; Yousef GM
    Biol Chem; 2010 Apr; 391(4):411-23. PubMed ID: 20180642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of kallikrein-related peptidases in the normal kidney and renal tumors: potential clinical implications.
    Gabril M; White NM; Moussa M; Chow TF; Metias SM; Fatoohi E; Yousef GM
    Biol Chem; 2010 Apr; 391(4):403-9. PubMed ID: 20128686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kallikreins as microRNA targets: an in silico and experimental-based analysis.
    Chow TF; Crow M; Earle T; El-Said H; Diamandis EP; Yousef GM
    Biol Chem; 2008 Jun; 389(6):731-8. PubMed ID: 18627289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis.
    Chow TF; Youssef YM; Lianidou E; Romaschin AD; Honey RJ; Stewart R; Pace KT; Yousef GM
    Clin Biochem; 2010 Jan; 43(1-2):150-8. PubMed ID: 19646430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma.
    Chow TF; Mankaruos M; Scorilas A; Youssef Y; Girgis A; Mossad S; Metias S; Rofael Y; Honey RJ; Stewart R; Pace KT; Yousef GM
    J Urol; 2010 Feb; 183(2):743-51. PubMed ID: 20022054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
    White NM; Bao TT; Grigull J; Youssef YM; Girgis A; Diamandis M; Fatoohi E; Metias M; Honey RJ; Stewart R; Pace KT; Bjarnason GA; Yousef GM
    J Urol; 2011 Sep; 186(3):1077-83. PubMed ID: 21784468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The miRNA-kallikrein axis of interaction: a new dimension in the pathogenesis of prostate cancer.
    White NM; Youssef YM; Fendler A; Stephan C; Jung K; Yousef GM
    Biol Chem; 2012 Apr; 393(5):379-89. PubMed ID: 22505520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNAs: a new frontier in kallikrein research.
    Yousef GM
    Biol Chem; 2008 Jun; 389(6):689-94. PubMed ID: 18627305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer.
    White NM; Chow TF; Mejia-Guerrero S; Diamandis M; Rofael Y; Faragalla H; Mankaruous M; Gabril M; Girgis A; Yousef GM
    Br J Cancer; 2010 Apr; 102(8):1244-53. PubMed ID: 20354523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of kallikrein-related peptidases: there is a whole new world out there.
    Pasic MD; Olkhov E; Bapat B; Yousef GM
    Biol Chem; 2012 Apr; 393(5):319-30. PubMed ID: 22505515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.
    Takahashi M; Yang XJ; Sugimura J; Backdahl J; Tretiakova M; Qian CN; Gray SG; Knapp R; Anema J; Kahnoski R; Nicol D; Vogelzang NJ; Furge KA; Kanayama H; Kagawa S; Teh BT
    Oncogene; 2003 Oct; 22(43):6810-8. PubMed ID: 14555994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.
    Hirota E; Yan L; Tsunoda T; Ashida S; Fujime M; Shuin T; Miki T; Nakamura Y; Katagiri T
    Int J Oncol; 2006 Oct; 29(4):799-827. PubMed ID: 16964377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
    Liu MY; Poellinger L; Walker CL
    Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
    Nakada C; Matsuura K; Tsukamoto Y; Tanigawa M; Yoshimoto T; Narimatsu T; Nguyen LT; Hijiya N; Uchida T; Sato F; Mimata H; Seto M; Moriyama M
    J Pathol; 2008 Dec; 216(4):418-27. PubMed ID: 18925646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parallel overexpression of seven kallikrein genes in ovarian cancer.
    Yousef GM; Polymeris ME; Yacoub GM; Scorilas A; Soosaipillai A; Popalis C; Fracchioli S; Katsaros D; Diamandis EP
    Cancer Res; 2003 May; 63(9):2223-7. PubMed ID: 12727843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The miRNA-kallikrein interaction: a mosaic of epigenetic regulation in cancer.
    Di Meo A; Wang C; Cheng Y; Diamandis EP; Yousef GM
    Biol Chem; 2018 Sep; 399(9):973-982. PubMed ID: 29604203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microarray analysis of microRNA expression in renal clear cell carcinoma.
    Huang Y; Dai Y; Yang J; Chen T; Yin Y; Tang M; Hu C; Zhang L
    Eur J Surg Oncol; 2009 Oct; 35(10):1119-23. PubMed ID: 19443172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma.
    Faragalla H; Youssef YM; Scorilas A; Khalil B; White NM; Mejia-Guerrero S; Khella H; Jewett MA; Evans A; Lichner Z; Bjarnason G; Sugar L; Attalah MI; Yousef GM
    J Mol Diagn; 2012 Jul; 14(4):385-92. PubMed ID: 22580180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response.
    Balamurugan K; Luu VD; Kaufmann MR; Hofmann VS; Boysen G; Barth S; Bordoli MR; Stiehl DP; Moch H; Schraml P; Wenger RH; Camenisch G
    Oncogene; 2009 Sep; 28(37):3274-85. PubMed ID: 19581925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of ketohexokinase is diminished in human clear cell type of renal cell carcinoma.
    Hwa JS; Kim HJ; Goo BM; Park HJ; Kim CW; Chung KH; Park HC; Chang SH; Kim YW; Kim DR; Cho GJ; Choi WS; Kang KR
    Proteomics; 2006 Feb; 6(3):1077-84. PubMed ID: 16372272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.